
Alithea Bio is a leader in precision immunotherapy, focusing on HLA peptide characterization through innovative immunopeptidomics and mass spectrometry. Their products, including HLA-Compass and NeoZOOM, empower drug developers by providing insights into immune-target interactions, enhancing the safety and efficacy of cancer treatments. With a commitment to revolutionizing cancer therapy, Alithea Bio combines advanced AI and bioinformatics to deliver actionable insights for immunotherapy development, positioning itself as a key player in the biotech industry.

Alithea Bio is a leader in precision immunotherapy, focusing on HLA peptide characterization through innovative immunopeptidomics and mass spectrometry. Their products, including HLA-Compass and NeoZOOM, empower drug developers by providing insights into immune-target interactions, enhancing the safety and efficacy of cancer treatments. With a commitment to revolutionizing cancer therapy, Alithea Bio combines advanced AI and bioinformatics to deliver actionable insights for immunotherapy development, positioning itself as a key player in the biotech industry.